BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4620092)

  • 21. Myelofibrosis and rapid thrombocytolysis. A case report.
    Kutti J; Bergström AL; Ridell B
    Acta Med Scand; 1977; 201(3):249-55. PubMed ID: 848365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet sequestration studies in man.
    Aster RH
    Br J Haematol; 1972 Mar; 22(3):259-63. PubMed ID: 4552216
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of prednisone and splenectomy in patients with idiopathic thrombocytopenic purpura: only splenectomy induces a complete remission.
    Louwes H; Vellenga E; Houwerzijl EJ; de Wolf JT
    Ann Hematol; 2001 Dec; 80(12):728-32. PubMed ID: 11797113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombokinetic studies in alcohol-related thrombocytopenia.
    Cowan DH
    J Lab Clin Med; 1973 Jan; 81(1):64-76. PubMed ID: 4682189
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of splenectomy on the clinical picture and survival time of platelets in children with idiopathic thrombocytopenic purpura.
    Kozlowska J; Rokicka R; Konopka L; Rechowicz K; Kotelba-Witkowska B; Pawelski S
    Pol Med Sci Hist Bull; 1970 Oct; 13(4):172-8. PubMed ID: 5530846
    [No Abstract]   [Full Text] [Related]  

  • 26. Acquired qualitative platelet disorders.
    Rao AK; Walsh PN
    Clin Haematol; 1983 Feb; 12(1):201-38. PubMed ID: 6340880
    [No Abstract]   [Full Text] [Related]  

  • 27. [Problems due to disorders of hemostasis in patients with platelet anomalies].
    Caen J
    Anesth Analg (Paris); 1968; 25(2):121-5. PubMed ID: 5691934
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of autoimmune thrombocytopenic purpura].
    Cajozzo A; Perricone R
    Minerva Med; 1982 Apr; 73(18):1179-83. PubMed ID: 7200576
    [No Abstract]   [Full Text] [Related]  

  • 29. Thrombocytokinetic examination in patients with hereditary thrombocytopenia.
    Fortýnová J; Farská I; Pudlák P; Krecek M; Májský A; Vopatová M
    Acta Univ Carol Med Monogr; 1972; 53():345-51. PubMed ID: 4677607
    [No Abstract]   [Full Text] [Related]  

  • 30. [The practical performance of blood platelet transfusion].
    Bucher U; Kummer H
    Schweiz Med Wochenschr; 1968 Oct; 98(42):1635-41. PubMed ID: 5748845
    [No Abstract]   [Full Text] [Related]  

  • 31. [Subleukemic myelosis - myelofibrosis].
    Demidova AV
    Ter Arkh; 1982; 54(9):135-43. PubMed ID: 7179142
    [No Abstract]   [Full Text] [Related]  

  • 32. [A case of primary myelofibrosis associated with massive splenomegaly (author's transl)].
    Koike K; Hattori A; Ito S; Tsukada T; Matsuoka M
    Rinsho Ketsueki; 1975 Nov; 16(11):1072-8. PubMed ID: 1240331
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of extensive splenomegaly in patients with myelofibrosis undergoing a reduced intensity allogeneic stem cell transplantation.
    Ciurea SO; Sadegi B; Wilbur A; Alagiozian-Angelova V; Gaitonde S; Dobogai LC; Akard LP; Hoffman R; Rondelli D
    Br J Haematol; 2008 Apr; 141(1):80-3. PubMed ID: 18324970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet kinetics in normal subjects and in haematological disorders; with special reference to thrombocytopenia and to the role of the spleen.
    Kotilainen M
    Scand J Haematol Suppl; 1969; 5():5-97. PubMed ID: 5264657
    [No Abstract]   [Full Text] [Related]  

  • 35. Physiology of platelets and immune thrombocytopenic purpura.
    Krishnadas KV
    J Assoc Physicians India; 1984 Jul; 32(7):585-90. PubMed ID: 6389492
    [No Abstract]   [Full Text] [Related]  

  • 36. The interpretation of platelet kinetic studies for the identification of sites of abnormal platelet destruction.
    Peters AM; Saverymuttu SH; Wonke B; Lewis SM; Lavender JP
    Br J Haematol; 1984 Aug; 57(4):637-49. PubMed ID: 6430336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet lifespan.
    Najean Y; Ardaillou N; Dresch C
    Annu Rev Med; 1969; 20():47-62. PubMed ID: 4894508
    [No Abstract]   [Full Text] [Related]  

  • 38. Platelet and fibrinogen kinetics with ( 75 Se)-selenomethionine in patients with myeloproliferative disorders.
    Brodsky I; Ross EM; Petkov G; Kahn SB
    Br J Haematol; 1972 Feb; 22(2):179-92. PubMed ID: 4500669
    [No Abstract]   [Full Text] [Related]  

  • 39. Myelofibrosis and megakaryoblastic transformation of chronic myelogenous leukemia associated with intrinsic platelet dysfunction: hematological, histological and ultrastructural findings.
    Cortelazzo S; D'Emilio A; Battista R; Ricciardi O; Dini E; Visonà A; Montaguti A; Pennelli N
    Haematologica; 1984; 69(6):671-81. PubMed ID: 6441743
    [No Abstract]   [Full Text] [Related]  

  • 40. [Bleeding due to pathophysiology of blood platelets].
    Yasunaga K
    Naika; 1970 Dec; 26(6):1021-9. PubMed ID: 4922779
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.